Multiple sclerosis (MS) is the number one cause of non-traumatic disability among young adults. MS is a chronic, incurable illness that destroys some of the body’s most basic neurological functions. Fortunately, there are now a slew of amazing medicines that often slow the disease considerably. These medicines can be the difference between whether or not a person spends her forties in a wheelchair.
Yet, insurance companies are increasingly requiring patients (or their physicians) to ask permission, known as pre-authorization, before the companies agree to pay for these critical medications.
(To read the rest of the article, please visit Forbes.)